7766-23-6

Basic information

• Product Name: 3-BROMO-2-METHYLPHENOL
• Synonyms: 3-BROMO-2-METHYLPHENOL;2-Bromo-6-hydroxytoluene, 3-Bromo-o-cresol;2-Methyl-3-broMophenol;Phenol, 3-bromo-2-methyl-
• CAS NO: 7766-23-6
• Molecular Formula: C₇H₇BrO
• Molecular Weight: 187.04
• Mol File: 7766-23-6.mol
• Article Data: 20

Chemical Properties

• Melting Point: 95°C
• Boiling Point: 220.79°C (rough estimate)
• Appearance: /
• Density: 1.3839 (rough estimate)
• Refractive Index: 1.5772 (estimate)
• Storage Temp.: Inert atmosphere,Room Temperature
• Solubility: Chloroform (Slightly), Methanol (Slightly)
• PKA: 9.35±0.10(Predicted)
• CAS DataBase Reference: 3-BROMO-2-METHYLPHENOL(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BROMO-2-METHYLPHENOL(7766-23-6)
• EPA Substance Registry System: 3-BROMO-2-METHYLPHENOL(7766-23-6)

Safety Data

• Hazardous Substances Data: 7766-23-6(Hazardous Substances Data)

Usage

General Description

3-Bromo-2-methylphenol is a compound with the chemical formula C7H7BrO. It is a derivative of phenol, having a bromine atom and a methyl group attached to the phenol ring. This chemical is commonly used as a disinfectant and antiseptic in personal care products and healthcare settings due to its strong antimicrobial properties. It is also utilized in the synthesis of pharmaceuticals and agrochemicals. Additionally, 3-Bromo-2-methylphenol is employed in research and laboratory settings as a reagent for organic synthesis. Overall, this chemical has a variety of applications and is important for its antimicrobial and synthetic capabilities.

Upstream product

• 69321-60-4 2,6-dibromotoluene 
• 603-83-8 3-nitro-o-tolylamine 
• 95-46-5 2-methylphenyl bromide 
• 55289-35-5 2-bromo-6-nitrotoluene 
• 95-48-7 ortho-cresol 
• 55289-36-6 3-bromo-2-methylaniline 

Downstream Products

• 573693-08-0 2-bromo-4-methoxy-3-methyl-phenylamine 
• 573693-11-5 2-bromo-4-methoxy-3-methyl-1-nitro-benzene 
• 573693-12-6 3-(2-bromo-4-methoxy-3-methyl-phenylamino)-4-methoxy-benzoic acid methyl ester 
• 573693-14-8 8-bromo-1,6-bis-(tert-butyl-diphenyl-silanyloxy)-7-methyl-9H-carbazole-4-carboxylic acid methyl ester 
• 573693-16-0 [1,6-bis-(tert-butyl-diphenyl-silanyloxy)-8-(2,5-dimethyl-hex-1-enyl)-7-methyl-9H-carbazol-4-yl]-methanol 
• 573693-15-9 1,6-bis-(tert-butyl-diphenyl-silanyloxy)-8-(2,5-dimethyl-hex-1-enyl)-7-methyl-9H-carbazole-4-carboxylic acid methyl ester 
• 1609641-53-3 1-(4-bromo-2-hydroxy-3-methylphenyl)but-3-en-1-one 
• 1458653-38-7 (3-(3-bromo-2-methylphenoxy)propyl)(methyl)sulfane 
• 1458653-37-6 1-bromo-2-methyl-3-(3-(methylsulfonyl)propoxy)benzene 
• 1430752-56-9 1-bromo-3-(cyclohexylmethoxy)-2-methylbenzene 
• 1430846-22-2 1-(3-bromo-2-methylphenoxy)tricyclo[3.3.1.1^3,7]decane 
• 1329991-97-0 C₉H₁₀BrIO 
• 1329991-96-9 C₉H₁₁BrO₂ 
• 93710-55-5 2-(2-bromo-6-methoxyphenyl)acetonitrile 

Relevant articles and documents

Discovery of novel small-molecule inhibitors of pd-1/pd-l1 interaction via structural simplification strategy

Blockade of the programmed cell death 1 (PD-1)/programmed cell death-ligand 1 (PD-L1) interaction is currently the focus in the field of cancer immunotherapy, and so far, several monoclonal antibodies (mAbs) have achieved encouraging outcomes in cancer tr

Novel biphenyl derivative as well as preparation method and medical application thereof

The invention relates to the field of medicinal chemistry, and discloses biphenyl derivatives with PD-1/PD-L1 inhibitory activity as well as a preparation method and application of the biphenyl derivatives. The invention further discloses a composition containing the biphenyl derivative with the PD-1/PD-L1 inhibitory activity or the pharmaceutically acceptable salt of the biphenyl derivative and a pharmaceutically acceptable carrier of the biphenyl derivative, and application of the biphenyl derivative in preparation of a PD-1/PD-L1 inhibitor. The compound can be used for treating tumors.

Divergent Enantioselective Synthesis of (Nor)illudalane Sesquiterpenes via Pd0-Catalyzed Asymmetric C(sp3)-H Activation

A divergent enantioselective synthesis of (nor)illudalane sesquiterpenes was designed by using a Pd0-catalyzed asymmetric C(sp3)-H arylation as a key step to control the isolated, highly symmetric quaternary stereocenter of the targe